Tuberculosis control in France - Evaluation of practice by a working group of the Société de Pneumologie de Langue Française;La lutte antituberculeuse en France: Évaluation des pratiques par un groupe de travail de la SPLF auprès des services de lutte antituberculeuse

Revue des Maladies Respiratoires

Volumn 22, Issue 1, 2005, Pages 45-54

  Fraisse, P ^a   Chouaid C ^b   Portel, L ^c   Antoun, F ^d   Blanc Jouvan, F ^e   Dautzenberg, B ^f  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c Centre Hospitalier Samuel Pozzi   (France)

^d Cellule Tuberculose   (France)

^e Free testing center for sexually transmitted infections CEGIDD   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Contact tracing; Prevention; Public health; Tuberculosis

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

AGING; ANTIBIOTIC THERAPY; ARTICLE; BCG VACCINATION; CHILD HEALTH CARE; FRANCE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MIGRATION; QUESTIONNAIRE; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 16444386739     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(05)85435-x     Document Type: Article

References (42)

1. Bouvet E, Abiteboul D, Antoun F, Bessa Z, Billy C, Dautzenberg D, Decludt B, Gaudelus J, Jarlier V, Lerasle S, Siruguet O, Vincent V: Prévention et prise en charge de la tuberculose en France. Synthèse et recommandations du groupe de travail du Conseil supérieur d'hygiène publique de France (2002-2003). Rev Mal Resp 2003; 20: 7S1-7S107.
2. Che D, Campese Ch, Decludt B: Les cas de tuberculose dé clarés en France en 2002. BEH 2004; 4: 13-5.
3. Noertjojo K, Tam CM, Chan SL, Tan J, Chan-Yeung M: Contact examination for tuberculosis, in Hong Kong is useful. Int J Tuberc Lung Dis 2002; 6: 19-24.
4. Chapitre 2 du titre 1 du livre 1 du Code de la santé publique, article L-3112-4.
5. Circulaire ministérielle n° 41 du 4 mai 1995 assortie d'un avis du CSHPF. BEH 1995; n° 25: 113-5.
6. Article L-3112-2 du Code de la santé publique: «la lutte contre la tuberculose et la lèpre relève de l'État».
7. Davies PD: A European framework for effective tuberculosis control. Eur Respir J 2002; 19: 590-2.
8. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC; World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group: European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-75.
9. Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE, Otaya M, Eisenach KD, Knowles L, Harvey S, Cave MD: Patterns of tuberculosis transmission in central Los Angeles. JAMA 1997; 278: 1159-63.
10. Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR: An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis 1991; 143: 257-61.
11. Verver S, Bwire R, Borgdorff MW: Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis 2001; 5: 419-25.
12. Callister MEJ, Barringer J, Thanabalasingam ST, Gair R, Davidson RN: Pulmonary tuberculosis among political asylum seekers screened at Heathrow Airport, London, 1995-9. Thorax 2002; 57: 152-6.
13. McAdam JM, Brickner PW, Scharer LL, Crocco JA, and Duff AE: The spectrum of tuberculosis in a New York City men's shelter clinic (1982-1988). Chest 1990; 97: 798-805.
14. Antoun F, Valin N, Chouaid Ch, Renard M, Dautzenberg B, Lalande V, Ayache B, Morin P, Sougakoff W, Thiolet JM, Truffot-Pernot C, Jarlier V, Decludt B: Épidémic de tuberculose dans un foyer de migrants à Paris en 2002. BEH 2003; 10: 58-60.
15. Article D-393 et D-394 du Code de procédure pénale, et le guide méthodologique de la circulaire n° 45/DGS/DH/DSS du 8 décembre 1994 relative à la prise en charge sanitaire des détenus et à leur protection sociale.
16. Hanau-Bercot B, Gremy I, Raskine L, Bizet J, Gutierrez MC, Boyer-Mariotte S, Bregeault A, Lagrange PH, Sanson Le Pors MJ: A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis 2000; 4: 853-9.
17. Hammett TM, Harmon MP, Rhodes W: The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92: 1789-94.
18. Chapitre 2 du titre 1 du livre 1 du code de la santé publique, Article L3112-5.
19. Murray CJ, Salomon JA: Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998; 95: 13881-6.
20. Javitz HS, Ward M: Value of antimicrobials in the prevention and treatment of tuberculosis in the United States. Int J Tuberc Lung Dis 2002; 6: 275-88.
21. American Thoracic Society: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
22. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, and Nguyen CH: Outcomes of Contact Investigations of Infectious Tuberculosis Patients. Am J Respir Crit Care Med Vol 162. pp 2033-2038, 2000.
23. Hubert B, Veccella M, Vergeaud H, Biarez P: Bilan du programme de lutte contre la tuberculose en Polynésie française, 1998-2001. BEH 2002; n° 41: 201-2.
24. MacIntyre CR, Plant AJ. Impact of policy and ptactice on the effectiveness of contact screening for tuberculosis. Prev Medicine 1998; 27: 830-7.
25. Wilce M, Shrestha-Kuwahara R, Taylor Z, Qualls N, Marks S: Tuberculosis contact investigation policies, practices, and challenges in 11 U.S. communities. J Public Health Manag Pract 2002; 8: 69-78.
26. Rieder HL: Epidemiologic basis of tuberculosis control. First edition 1999. International Union Against Tuberculosis and Lung Disease 68, boulevard Saint-Michel, 75006 Paris, 161p.
27. Behr MA, Hopewell PC, Paz EA, Kawamura LM, Schecter GF, Small PM: Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158: 465-9.
28. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM; Contact Investigation Study Group: Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287: 991-5.
29. Ansari S, Thomas S, Campbell IA, Furness L, Evans MR: Refined tuberculosis contact tracing in a low incidence area. Respir Med 1998; 92: 1127-31.
30. van Deutekom H, Hoijng SP, de Haas PEW, Langendam MW, Horsman A, van Soolingen D, Coutinh RA: Clustered Tuberculosis Cases: Do They Represent Recent Transmission and Can They Be Detected Earlier? Am J Respir Crit Care Med 2004; 169: 806-10.
31. Pitman R, Jarman B, Coker R: Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis 2002; 6: 485-91
32. Centers for Disease Control and Prevention. Targeted tuberculin testing and treat-ment of latent tuberculosis infection. MMWR 2000; 49, RR-6: 1-54.
33. Wang PD, Lin RS: Tuberculosis transmission in the family. J Infect 2000; 41: 249-51.
34. Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970; 17: 28-106.
35. Wallgren A: The time-table of tuberculosis. Tubercle 1948: 245-51.
36. Sutherland E: The ten-year incidence of clinical tuberculosis following "conversion" in 2 550 individuals aged 14 to 19 years. TSRU Progress Report. KNCV, The Hague, Netherlands.
37. Code de la santé publique, chapitre 2, titre 1, livre 1, articles L 3112-1 et L 3112-3; arrêté du 5 septembre 1996 relatif à la pratique de la vaccination par le vaccin antituberculeux BCG et au test tuberculinique, JO du 7-9-1996.
38. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
39. Article L3112-1 du Code de santé publique, Loi n°°2004-806 du 9 août 2004 art.4, JO du 11 août 2004.
40. La tuberculose, le malade, le soignant et la société. Formation continue du Département d'éducation permanente de l'Université Louis Pasteur, Strasbourg, section Sciences de la santé, E. Weitzenblum et Ph Fraisse coordinateurs, http://depulp.u- strasbg.fr.
41. Société de pneumologie de langue française. Recommandations de la Société de pneumologie de langue française sur la prise en charge de la tuberculose en France. Rev Mal Respir 2004; 21: 414-20.
42. Cadranel J, Delacourt C: Diagnostic et traitement de l'infection tuberculeuse latente: un texte qui doit être clarifié pour le rendre applicable. Rev Mal Respir 2004; 21: 255-8.